European public procurement and grants data from official registers · Data as of 18 November 2026; updated daily.

Tenders

Cardiovascular drug tenders in Slovakia

Cardiovascular drug tenders in Slovakia: 82 listed on GranTender since 2024; 2 open now. The median awarded contract value is about €43,000 (257 contracts with a stated value). Buyers with the most tenders: Všeobecná zdravotná poisťovňa, a. s. (35), Fakultná nemocnica s poliklinikou Žilina (11) and Fakultná nemocnica s poliklinikou F. D. Roosevelta Banská Bystrica (7); suppliers with the most contract awards: MED - ART, spol. s r.o. (125), UNIPHARMA - 1. slovenská lekárnická akciová spoločnosť (81) and PHOENIX Zdravotnícke zásobovanie, a.s. (24). Sources: Centrálny register zmlúv and TED. In 2025 the median contract value was €52,000; 23% of contracts drew a single bid (2.6 bids on average). Data as of 18 November 2026; updated daily.

Tenders
82
Open tenders
2
Awards
291
Awarded value awarded
€102,917,679
Awarded value framework ceiling
€28,841,838
Median contract value awarded
≈ €43,000
Median contract value framework ceiling
≈ €41,000
Average bids per contract
2.1
Tenders in 2025
28 -7% on 2024

Median: contracts with a stated value, rounded. Average bids: contracts where the number of bids is published.

Value kinds: awarded — the value in the award decision; contract — the value of the signed or amended contract; paid — the amount actually paid; framework ceiling — the maximum of a framework agreement, given with every winner, not money spent. Different kinds are never added together.

Open tenders

TenderBuyerEstimated valueStatusPublished
Antihemoragiká - Fibrinogenum humanumNemocnica Poprad, a.s.€56,912Open5 November 2026
Lieky pre potreby UNLP Košice v rozsahu antiinfektíva a antitrombotikáUniverzitná nemocnica L. Pasteura Košice—Open5 November 2026

Latest tenders

TenderBuyerEstimated valueStatusPublished
Antihemoragiká - Fibrinogenum humanumNemocnica Poprad, a.s.€56,912Open5 November 2026
Lieky pre potreby UNLP Košice v rozsahu antiinfektíva a antitrombotikáUniverzitná nemocnica L. Pasteura Košice—Open5 November 2026
AntihemoragikáFakultná nemocnica s poliklinikou Žilina€187,936Closed29 September 2026
Ľudský fibrinogén a ľudský protrombínový komplexStredoslovenský ústav srdcových a cievnych chorôb, a.s.€1,392,294Closed25 September 2026
Lieky ATC skupiny B02BD02, účinná látka Koagulačný faktor VIIIVšeobecná zdravotná poisťovňa, a. s.€2,483,427Closed24 September 2026
Lieky ATC skupiny B02BD06 Koagulačný faktor VIII a von Willebrandov faktor v kombináciiVšeobecná zdravotná poisťovňa, a. s.€1,621,103Closed26 August 2026
Lieky ATC skupiny B02BD06 účinná látka Koagulačný faktor VIII a von Willebrandov faktor v kombináciiVšeobecná zdravotná poisťovňa, a. s.€1,481,916Closed26 August 2026
Lieky RVO/3793/2026 v rozsahu Anticoagulancia, Bronchodilatancia, Antiemetiká, Systémové a hormonálne prípravky okrem pohlavných hormónov pre potreby FNsP F. D. Roosevelta Banská Bystrica".Fakultná nemocnica s poliklinikou F. D. Roosevelta Banská Bystrica€1,783,234Closed11 August 2026
SAKUBITRIL/VALSARTANNárodný ústav srdcových a cievnych chorôb, a.s. Bratislava€62,842Awarded27 July 2026
Lieky ATC skupiny B02BD02 Koagulačný faktor VIII, parent rekomb (simoktokog alfa)Všeobecná zdravotná poisťovňa, a. s.€1,512,362Awarded20 July 2026
Lieky ATC skupiny B02BD04 Koagulačný faktor IXVšeobecná zdravotná poisťovňa, a. s.€1,026,846Awarded20 July 2026
Lieky ATC skupiny B02BD02 Koagulačný faktor VIII, parent (rurioktokog alfa pegol)Všeobecná zdravotná poisťovňa, a. s.€1,399,066Awarded16 July 2026
Lieky ATC skupiny B02BD04Všeobecná zdravotná poisťovňa, a. s.€9,094,943Awarded16 July 2026
Antihemoragiká 2026Nemocnica Poprad, a.s.€150,027Awarded19 June 2026
Lieky ATC skupiny B02BD02Všeobecná zdravotná poisťovňa, a. s.€4,103,168Awarded18 June 2026
Lieky ATC skupiny B02BD05Všeobecná zdravotná poisťovňa, a. s.€825,250Awarded18 June 2026
Lieky ATC skupiny B02BD11Všeobecná zdravotná poisťovňa, a. s.€969,720Awarded4 June 2026
Liečivá pre srdcovocievny systém , Liečivá pre močovopohlavný systém a pohlavné hormónyFakultná nemocnica s poliklinikou Žilina€91,727Awarded26 May 2026
Lieky ovplyvňujúce koaguláciu a hemodynamikuNárodný ústav srdcových a cievnych chorôb, a.s. Bratislava€468,088Awarded13 April 2026
Lieky ATC skupiny B02BD04Všeobecná zdravotná poisťovňa, a. s.€585,872Awarded12 February 2026

Competition and prices

In 2025, half of the contracts were worth between €13,000 and €210,000, with a median of €52,000 (98 contracts with a stated awarded value). Contracts drew 2.6 bids on average (median 2) and 23% drew a single bid — based on 106 contracts with a known number of bids. Compared with 2024, in 2025 the median value rose 6% and the share of single-bid contracts fell from 31% to 23%. The usual procedures: open procedure (100%) — of 82 tenders with a stated procedure.

The most contracts went to MED - ART, spol. s r.o. (125), UNIPHARMA - 1. slovenská lekárnická akciová spoločnosť (81) and PHOENIX Zdravotnícke zásobovanie, a.s. (24) — together 79% of all contracts.

YearContractsMedian valueMiddle half of valuesBids on averageSingle bid
202455€49,000€15,000 – €610,0002.131% (55)
2025106€52,000€13,000 – €210,0002.623% (106)
2026 (so far)129€33,000€9,200 – €150,0001.843% (129)
All years291€43,000€11,000 – €170,0002.133% (291)

Values: contracts with a stated value in EUR, each value kind on its own (awarded or contract value), approximate (±3 %). Bids: contracts of procedures with competition whose number of bids the source publishes (1–100 bids); the sources publish it for some contracts only (TED ≈ 3 in 4, Spain all, Poland about half, Italy few), so each figure states its base and is shown from 20 contracts. A contract counts in the year of its award (else of its tender). Figures as of 13 November 2026, recomputed every week.

Where you have a chance

Since 1 November 2024, 33% of the 239 contracts with a known number of bids had a single bid; the median was 2 bids. The number of bids is known for 239 of the 239 contracts from procedures with competition.

Buyers who often get few offers

The buyers below usually received one or two offers per contract — an offer from you would stand out.

Contracts awarded since 1 November 2024 (the last 24 months). Bids as the source publishes them, 1 to 100 per contract, in procedures with competition only (a direct award has one offer by design). As of 13 November 2026.

Main CPV divisions

CPV codes of this topic

  • 33620000 Medicinal products for the blood, blood-forming organs and the cardiovascular system

A tender belongs here when its main CPV code starts with one of these codes; a tender without a usable CPV code (or with a general one) is matched by words of its title. A tender may belong to up to three topics.

Cardiovascular and anticoagulant drugs in neighbouring countries

Today, 70 tenders in the same niche are open in neighbouring countries.

Public tenders in the EU and the EEA are open to companies from every EU and EEA country on the same terms as local ones, and to companies from countries with a procurement agreement with the EU (such as Switzerland, the United Kingdom and Ukraine) for the contracts it covers. In countries outside the EU and the EEA, the notice says who may bid. Open means the deadline has not passed (today's date). Neighbours: countries with a land border, a fixed link or a short sea crossing.

Expected soon5

ExpectedBuyerWhatWhy we expect itConfidence
now – Mar 2027
contract ends
Východoslovenský onkologický ústav, a.s.Cardiovascular and anticoagulant drugs
Lieky pre potreby VOU a.s
Typical value: ≈ €5,400
The current contract with UNIPHARMA - 1. slovenská lekárnická akciová spoločnosť ends on 16 April 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 12/2025
medium
Dec 2026 – May 2027
contract ends
Žilinský samosprávny krajCardiovascular and anticoagulant drugs
Lieky pre Kysuckú nemocnicu s poliklinikou Čadca
Typical value: ≈ €510,000
The current contract with UNIPHARMA - 1. slovenská lekárnická akciová spoločnosť ends on 17 June 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 03/2025
medium
Dec 2026 – Feb 2027
every year
Fakultná nemocnica s poliklinikou F. D. Roosevelta Banská BystricaCardiovascular and anticoagulant drugs
"Lieky RVO/3891/2025 v rozsahu Antianemiká, Soli a Iony, Vazodilatancia, Oftalmologiká pre potreby FNsP F. D. Roosevelta Banská Bystrica"
Typical value: ≈ €400,000
The buyer has published cardiovascular drug tenders every year in January since 2024.
Earlier tenders: 01/2026, 02/2025, 01/2024
high
Jan – Jun 2027
contract ends
Národný onkologický ústavCardiovascular and anticoagulant drugs
Dodávka liekov a liečiv V.
Typical value: ≈ €100,000
The current contract with INTEC PHARMA s.r.o. ends on 24 July 2027 (from its stated duration); no new tender has been published yet. The current contract with PHOENIX Zdravotnícke zásobovanie, a.s. ends on 23 October 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 04/2025, 06/2025
high
Apr – Jun 2027
every year
Nemocnica Poprad, a.s.Cardiovascular and anticoagulant drugs
Antihemoragiká 2026
Typical value: ≈ €67,000
The buyer has published cardiovascular drug tenders every year in May since 2024.
Earlier tenders: 06/2026, 05/2025, 04/2024
medium

Forecast from public data, not an announcement. Methodology.

Cardiovascular and anticoagulant drugs by city

Cardiovascular and anticoagulant drugs in other countries

Cardiovascular and anticoagulant drugs across Europe

Topics in Health, medical equipment and medicines

Questions and answers

Which cardiovascular drug tenders in Slovakia are open now?
2 of the 82 cardiovascular drug tenders in Slovakia listed on GranTender are open for bids. For example: Antihemoragiká - Fibrinogenum humanum; Lieky pre potreby UNLP Košice v rozsahu antiinfektíva a antitrombotiká.
Where can I find cardiovascular drug tenders in Slovakia?
GranTender lists them in one place, from Centrálny register zmlúv and TED, with their buyers, winners and contract values; 2 are open now. Search in one country at a time (the first 5 results) is free; search across all countries at once, full result lists, saved keywords with an e-mail once a week and exports come with a plan.
Who wins the most cardiovascular drug tenders in Slovakia?
By number of contracts won: MED - ART, spol. s r.o. (125), UNIPHARMA - 1. slovenská lekárnická akciová spoločnosť (81), PHOENIX Zdravotnícke zásobovanie, a.s. (24).
Which buyers publish the most cardiovascular drug tenders in Slovakia?
By number of tenders: Všeobecná zdravotná poisťovňa, a. s. (35), Fakultná nemocnica s poliklinikou Žilina (11), Fakultná nemocnica s poliklinikou F. D. Roosevelta Banská Bystrica (7).
Which CPV codes belong to “Cardiovascular and anticoagulant drugs”?
33620000 Medicinal products for the blood, blood-forming organs and the cardiovascular system; plus tenders without a usable CPV code whose title names the topic.
How many bids do cardiovascular drug tenders in Slovakia receive on average?
In 2025, contracts drew 2.6 bids on average (median 2) and 23% drew a single bid — based on 106 contracts with a known number of bids.
How much are contracts for cardiovascular drug tenders in Slovakia worth?
In 2025, half of the contracts were worth between €13,000 and €210,000, with a median of €52,000 (98 contracts with a stated awarded value). Compared with 2024, in 2025 the median value rose 6% and the share of single-bid contracts fell from 31% to 23%.
Which procedures are used for cardiovascular drug tenders in Slovakia?
The usual procedures: open procedure (100%) — of 82 tenders with a stated procedure.
Which buyers get few offers in cardiovascular drug tenders in Slovakia?
Since 1 November 2024, these buyers usually received one or two offers per contract: Univerzitná nemocnica Martin (median 2 bids over 42 contracts), Východoslovenský onkologický ústav, a.s. (median 2 bids over 37 contracts) and Národný ústav srdcových a cievnych chorôb, a.s. Bratislava (median 2 bids over 33 contracts). Since 1 November 2024, 33% of the 239 contracts with a known number of bids had a single bid; the median was 2 bids.

CPV 2008 (Regulation (EC) No 213/2008), © European Union, Publications Office — via the eForms SDK, CC BY 4.0.